ARTES and Burnet Institute publish data on new malaria vaccine candidates

For more information:

Nov­el Virus-Like Par­ti­cle Vac­cine Encod­ing the Cir­cum­sporo­zoite Pro­tein of Plas­mod­i­um fal­ci­parum Is Immuno­genic and Induces Func­tion­al Anti­body Respons­es in Mice.

ARTES backs “Initiative against Corona”

Never again 2020: Let’s get vaccinated -

Initiative against Corona” calls for vaccinations

Health service provider NOVENTI and the four leading vaccine manufacturers in Germany want to increase the population’s willingness to vaccinate through a Germany-wide campaign
- “Dispute must give way to factual clarification” posters for all 19,000 pharmacies in Germany, among others

Nev­er again 2020: Let’s get vac­ci­nat­ed.” This is the mot­to of the nation­wide cam­paign by health ser­vice provider NOVENTI as part of the “Ini­tia­tive against Coro­na.” Its aim is to relieve the pop­u­la­tion of con­cerns about vac­ci­na­tion through objec­tive edu­ca­tion and inten­si­fy the fight against the coro­na virus. The ini­tia­tive is sup­port­ed by the lead­ing vac­cine man­u­fac­tur­ers BioN­Tech, Cure­Vac, Artes Biotech­nol­o­gy and IDT Biologi­ka. Posters to be post­ed in dis­play win­dows have been deliv­ered to all 19,000 phar­ma­cies in Germany.

Accord­ing to a Hei­del­berg Uni­ver­si­ty study, only 46 per­cent of peo­ple liv­ing in Ger­many are cur­rent­ly will­ing to be vac­ci­nat­ed. How­ev­er, in order to get the Covid 19 pan­dem­ic under con­trol and relieve the health sys­tem, a sig­nif­i­cant­ly high­er vac­ci­na­tion rate of around 60 to 70 per­cent is impor­tant, accord­ing to WHO. There­fore, the campaign’s aim is to increase will­ing­ness in Ger­many to vaccinate.

Fac­tu­al infor­ma­tion is the best immu­niza­tion against vac­ci­na­tion doubts”

Phar­ma­cists are the on-site health experts who can pro­vide infor­ma­tion about vac­ci­na­tion against Covid-19 indi­vid­u­al­ly and nation­wide through­out Ger­many,” says Dr. Her­mann Som­mer, CEO of NOVENTI Health SE. “We use this fact to con­tin­ue our ‘Ini­tia­tive against Coro­na,’ because fac­tu­al infor­ma­tion is the best immu­niza­tion against ram­pant vac­ci­na­tion doubts. We must address that now — regard­less of the cur­rent amount of vac­cine — because per­son­al atti­tudes are slow to change. Fac­tu­al clar­i­fi­ca­tion must pre­vail over the cur­rent­ly pre­vail­ing dis­pute. Because this unset­tles the pop­u­la­tion and reduces the will­ing­ness to vac­ci­nate. We need com­pe­tent con­tent-relat­ed con­tacts for the pop­u­la­tion — such as the phar­ma­cists — and role mod­els from all parts of soci­ety who car­ry the top­ic in their hearts. Because it’s a mat­ter of each individual’s life.”

Phar­ma­cies as a place for con­tent-relat­ed information”

It is impor­tant that peo­ple who are wor­ried about the COVID-19 vac­cine can obtain infor­ma­tion based on facts and that they also feel ful­ly informed,” empha­sizes Dr. Michael Boehler, Man­ag­ing Direc­tor for BioN­Tech in Ger­many, which has devel­oped a vac­cine against Covid-19 in col­lab­o­ra­tion with the US phar­ma­ceu­ti­cal com­pa­ny Pfiz­er. “The ‘Ini­tia­tive against Coro­na’ brings dis­cus­sions about vac­ci­na­tion to the right place for con­tent-relat­ed infor­ma­tion: in the phar­ma­cies.” Franz-Wern­er Haas, CEO of the Tübin­gen-based biotech com­pa­ny Cure­Vac, is con­vinced that will­ing­ness to vac­ci­nate can be increased “if seri­ous and inde­pen­dent con­tacts such as phar­ma­cies pro­vide infor­ma­tion and rec­om­mend vac­ci­na­tion. That is why we are hap­py to sup­port NOVEN­TI’s ‘Ini­tia­tive against Corona’.”

It only hap­pens by work­ing togeth­er — regard­less of nation­al­i­ty, ori­gin or religion”

The cam­paign mot­to aims at the wish that is cer­tain­ly at the top of most peo­ple’s wish-lists for the new year: Nev­er again 2020,” explains Dr. Sil­vio Kusche, CMO of NOVENTI. “That only hap­pens by work­ing togeth­er. With our over­ar­ch­ing ini­tia­tive, we actu­al­ly want to address every­one liv­ing in Ger­many and have there­fore imple­ment­ed the motifs in the five most fre­quent­ly spo­ken languages​in Ger­many, name­ly Ger­man, Eng­lish, French, Russ­ian and Turk­ish. Media part­ner among oth­ers is the Turk­ish news­pa­per Hür­riyet. Because the pan­dem­ic affects us all, regard­less of nation­al­i­ty, ori­gin or reli­gion. In addi­tion to tech­ni­cal com­pe­tence, phar­ma­cies are also ide­al for the cov­er­age, because they have — in con­trast to med­ical prac­tices, clin­ics and vac­ci­na­tion cen­ters — large shop win­dows that every­one pass­es. That’s what we use for our poster campaign.”


NOVENTI bears the costs for pro­duc­ing and dis­trib­ut­ing the posters, and the four vac­cine man­u­fac­tur­ers lend sup­port by pro­vid­ing infor­ma­tion about the vac­ci­na­tions. You can find more infor­ma­tion and the poster motif “Nev­er again 2020” at and

ARTES joins global combat against Corona

ARTES attends BioEurope Spring


ARTES attends BioEurope 2019

ARTES and Burnet Institute publish data on production and immunogenicity of malaria transmission-blocking vaccine candidates

ARTES Biotech­nol­o­gy and Bur­net Insti­tute recent­ly pub­lished data on the effi­cient pro­duc­tion of malar­ia vac­cine can­di­dates using virus-like par­ti­cles (VLP) pre­sent­ing malar­ia trans­mis­sion-stage anti­gens, which were capa­ble of induc­ing trans­mis­sion-block­ing antibodies.

ARTES attends BioEurope Spring 2019

Meet us at the Bio-Europe Spring 2018 tak­ing place in Vien­na, Aus­tria March 25 ‑27. Volk­er Jen­zelews­ki, Direc­tor Tech­nol­o­gy at ARTES, will be present in the One-on-One Part­ner­ing pre­sent­ing ARTES’ inno­v­a­tive range of cell line and process devel­op­ment solu­tions for bio-phar­ma­ceu­ti­cal and vac­cine products.